Lower cGAS or STING expression in cancer samples was correlated to worse patient outcomes with hepatocellular carcinoma and lung adenocarcinoma, suggesting the importance of functional cGAS-STING axis activity in proper tumor suppression (77, 81). The gene discussed is STING1; the disease is hepatocellular carcinoma.